They provided evidence that ApoA1 reduced tumor angiogenesis and recruited tumor cell targeting macrophages and CD8+ cytotoxic T cells, thereby altering the tumor microenvironment to one less permissive for tumor development (167, 168). The gene discussed is APOA1; the disease is neoplasm.